Taichi Yabuno

Suggest Changes
  • Citations Per Year
Learn More
A prospective trial has not been performed to investigate associations between quality of life (QOL), adverse events (AEs), and overall survival (OS) in the first-line treatment with cetuximab plus(More)
  • 1